Literature DB >> 12716907

PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4.

Taruna Arora1, Bin Liu, Hongchin He, Jenny Kim, Theresa L Murphy, Kenneth M Murphy, Robert L Modlin, Ke Shuai.   

Abstract

In response to interleukin 12 (IL-12) stimulation, a latent cytoplasmic transcription factor, Stat4 (signal transducer and activator of transcription 4), becomes tyrosine-phosphorylated and translocates into the nucleus where it binds to DNA to activate transcription. Cofactors that can directly bind and regulate Stat4 activity have not been described. We report here that PIASx, a member of the protein inhibitor of activated STAT (PIAS) family, is a negative regulator of Stat4. PIASx becomes associated with Stat4 following IL-12 stimulation in vivo. PIASx inhibits IL-12-stimulated and Stat4-dependent gene activation in human T cells. PIASx does not inhibit the DNA binding activity of Stat4. Instead PIASx is present in the Stat4-DNA binding complex. Finally the inhibitory activity of PIASx on Stat4-mediated gene activation is abolished by the histone deacetylase inhibitor trichostatin A. Our results suggest that PIASx may function as a co-repressor of Stat4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716907     DOI: 10.1074/jbc.C300119200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

2.  PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.

Authors:  Toru Kubota; Mayumi Matsuoka; Songxiao Xu; Noriyuki Otsuki; Makoto Takeda; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

3.  Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7).

Authors:  Christian Meinert; Florian Gembardt; Ilka Böhme; Anja Tetzner; Thomas Wieland; Barry Greenberg; Thomas Walther
Journal:  J Proteomics       Date:  2015-09-24       Impact factor: 4.044

Review 4.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

Review 5.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

Review 6.  Multiple transcription factor families regulate axon growth and regeneration.

Authors:  Darcie L Moore; Jeffrey L Goldberg
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

7.  Negative regulation of NF-kappaB signaling by PIAS1.

Authors:  Bin Liu; Randy Yang; Kelly A Wong; Crescent Getman; Natalie Stein; Michael A Teitell; Genhong Cheng; Hong Wu; Ke Shuai
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

8.  PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins.

Authors:  Keiko Kawai-Kowase; Meena S Kumar; Mark H Hoofnagle; Tadashi Yoshida; Gary K Owens
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.

Authors:  Kenta Iwasaki; Kiros Hailemariam; Yoshiaki Tsuji
Journal:  J Biol Chem       Date:  2007-06-12       Impact factor: 5.157

10.  Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.

Authors:  Yan Ling; Umesh T Sankpal; Andrea K Robertson; James G McNally; Tatiana Karpova; Keith D Robertson
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.